Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B F Haynes

Showing results (241-250 of 263) with videos related to

Pageof 27
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1986
Immunoglobulin and T-cell receptor gene rearrangement and expression in human lymphoid leukemia cells at different stages of maturationM P Davey, K F Bongiovanni, W Kaulfersch, et al.
The Journal of Experimental Medicine|March 1, 1993
Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope proteinB F Haynes, L O Arthur, P Frost, et al.
AIDS Research and Human Retroviruses|January 10, 2002
Thymopoiesis in HIV-infected adults after highly active antiretroviral therapyM L Markert, A P Alvarez-McLeod, G D Sempowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1990
Synthetic peptides containing T and B cell epitopes from human immunodeficiency virus envelope gp120 induce anti-HIV proliferative responses and high titers of neutralizing antibodies in rhesus monkeysM K Hart, T J Palker, T J Matthews, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1993
Induction of HIVMN neutralizing antibodies in primates using a prime-boost regimen of hybrid synthetic gp120 envelope peptidesB F Haynes, J V Torres, A J Langlois, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1991
A tyrosine kinase physically associates with the beta-subunit of the human IL-2 receptorM R Fung, R M Scearce, J A Hoffman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1989
Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopesT J Palker, T J Matthews, A Langlois, et al.
AIDS (London, England)|August 26, 1998
Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research InitiativeJ A Bartlett, S S Wasserman, C B Hicks, et al.
Transactions of the Association of American Physicians|January 1, 1993
Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategyB F Haynes, Y Yasutomi, J V Torres, et al.
The American Journal of Medicine|July 1, 1988
Human T-cell lymphotropic virus I and adult T-cell leukemia: report of a cluster in North CarolinaJ B Weinberg, R A Spiegel, D L Blazey, et al.
Pageof 27

Showing results (241-250 of 263) with videos related to

Sort By:
Pageof 27
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1986
Immunoglobulin and T-cell receptor gene rearrangement and expression in human lymphoid leukemia cells at different stages of maturationM P Davey, K F Bongiovanni, W Kaulfersch, et al.
The Journal of Experimental Medicine|March 1, 1993
Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope proteinB F Haynes, L O Arthur, P Frost, et al.
AIDS Research and Human Retroviruses|January 10, 2002
Thymopoiesis in HIV-infected adults after highly active antiretroviral therapyM L Markert, A P Alvarez-McLeod, G D Sempowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1990
Synthetic peptides containing T and B cell epitopes from human immunodeficiency virus envelope gp120 induce anti-HIV proliferative responses and high titers of neutralizing antibodies in rhesus monkeysM K Hart, T J Palker, T J Matthews, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1993
Induction of HIVMN neutralizing antibodies in primates using a prime-boost regimen of hybrid synthetic gp120 envelope peptidesB F Haynes, J V Torres, A J Langlois, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1991
A tyrosine kinase physically associates with the beta-subunit of the human IL-2 receptorM R Fung, R M Scearce, J A Hoffman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1989
Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopesT J Palker, T J Matthews, A Langlois, et al.
AIDS (London, England)|August 26, 1998
Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research InitiativeJ A Bartlett, S S Wasserman, C B Hicks, et al.
Transactions of the Association of American Physicians|January 1, 1993
Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategyB F Haynes, Y Yasutomi, J V Torres, et al.
The American Journal of Medicine|July 1, 1988
Human T-cell lymphotropic virus I and adult T-cell leukemia: report of a cluster in North CarolinaJ B Weinberg, R A Spiegel, D L Blazey, et al.
Pageof 27